drugset / Trial / NCT06533475

A Study to Assess the Bioavailability of a New Tablet Formulation of Minzasolmin and the Effect of Food in Healthy Participants

NCT06533475

Phase 1 Completed 18 enrolled UCB Biopharma SRL
RandomizedCrossoverOpen-labelOther

Summary

The purpose of the study is to estimate the relative bioavailability of a new minzasolmin tablet formulation versus reference 'granules in capsule' formulation in healthy participants and to evaluate the effect of food with the new tablet formulation on the pharmacokinetics (PK) of minzasolmin.

Timeline

Start
2024-09-06
Primary completion
2024-11-17
Completion
2024-11-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Minzasolmin Small molecule

Indications

No indication recorded.